THE DNA METHYLATION MACHINERY AS A TARGET FOR ANTICANCER THERAPY

Authors
Citation
M. Szyf, THE DNA METHYLATION MACHINERY AS A TARGET FOR ANTICANCER THERAPY, Pharmacology & therapeutics, 70(1), 1996, pp. 1-37
Citations number
328
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
01637258
Volume
70
Issue
1
Year of publication
1996
Pages
1 - 37
Database
ISI
SICI code
0163-7258(1996)70:1<1:TDMMAA>2.0.ZU;2-N
Abstract
DNA methylation is now recognized as an important mechanism regulating different functions of the genome; gene expression, replication, and cancer, Different factors control the formation and maintenance of DNA methylation patterns. The level of activity of DNA methyltransferase (MeTase) is one factor. Recent data suggest that some oncogenic pathwa ys can induce DNA MeTase expression, that DNA MeTase activity is eleva ted in cancer, and that inhibition of DNA MeTase can reverse the trans formed state. What are the pharmacological consequences of our current understanding of DNA methylation patterns formation! This review will discuss the possibility that DNA MeTase inhibitors can serve as impor tant pharmacological and therapeutic tools in cancer and other genetic diseases.